Aurinia Pharmaceuticals Inc. announced that a post-hoc analysis of the 52-week, Phase III AURORA 1 study presented at at LUPUS 2025, the 16th International Congress on SLE, showed… read more.
Merit Medical Systems Inc. announced that the 12-month results from the single-arm cohort of the WAVE trial (NCT04540302) were presented at the annual Charing Cross Symposium held in… read more.
Sobi will have a strong scientific presence at this year’s ERA congress in Vienna (4-7 June) with a total of eight presentations: six oral presentations and two posters…. read more.
At any given time, about 100,000 people in the U.S. are waiting to become kidney transplant recipients. Roughly one-fifth of those get a new kidney each year, but… read more.
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study… read more.
scPharmaceuticals Inc., announced that the FDA has approved the supplemental New Drug Application (sNDA) for Furoscix to expand the indication to include treatment of edema in patients with… read more.
NICE (UK): 1.1 Vadadustat is recommended, within its marketing authorisation, as an option for treating symptomatic anaemia caused by chronic kidney disease in adults having maintenance dialysis. Vadadustat… read more.
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it can be difficult to manage with opioid medication and other conventional… read more.
Novo Nordisk announced that the FDA has approved Ozempic (semaglutide injection) to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to… read more.
30 December 2024-Orion Corporation and Marinus Pharmaceuticals, Inc. have decided to mutually terminate their European wide marketing and distribution agreement for ganaxolone. Marinus regains ganaxolone’s commercial rights in… read more.
Merck Inc., ( known as MSD outside of the United States and Canada), announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted… read more.
Newly published research suggests an association between COVID-19 infection and accelerated kidney function decline, especially among people who had been hospitalized for the infection. The findings were published… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
